Reset
Id
Protein
PTM type
Site
Species
Disease
Cell line
Drug
Regulatory
Confidence score(level)
Ref.
acc2201 AKT phosphorylation Ser473 human Colorectal Cancer HT29 Magnolol Associated 4.0 (Moderate) 32429376
acc2202 AKT phosphorylation Ser473 human Colorectal Cancer CT26 Magnolol Associated 4.0 (Moderate) 32429376
acc2203 PKCdelta phosphorylation Thr507 human Colorectal Cancer HT29 Rottlerin Associated 4.0 (Moderate) 32429376
acc2204 PKCdelta phosphorylation Thr507 human Colorectal Cancer CT26 Rottlerin Associated 4.0 (Moderate) 32429376
acc2205 NF-kappaB phosphorylation Ser276 human Colorectal Cancer HT29 Rottlerin Associated 4.0 (Moderate) 32429376
acc2206 NF-kappaB phosphorylation Ser276 human Colorectal Cancer CT26 Rottlerin Associated 4.0 (Moderate) 32429376
acc2207 ERK1 phosphorylation Thr202 human Breast Cancer MCF7 VPA Associated 4.0 (Moderate) 34263655
acc2208 ERK1 phosphorylation Tyr204 human Breast Cancer MDA-MB-231 VPA Associated 4.0 (Moderate) 34263655
acc2209 ERK2 phosphorylation Thr185 human Breast Cancer MCF7 VPA Associated 4.0 (Moderate) 34263655
acc2210 ERK2 phosphorylation Tyr187 human Breast Cancer MDA-MB-231 VPA Associated 4.0 (Moderate) 34263655
acc2211 PLK1 phosphorylation Thr210 human Prostate Cancer PC3 KUD773 Enhancing 5.0 (High) 25563361
acc2212 PLK1 phosphorylation Thr210 human Prostate Cancer DU145 KUD773 Enhancing 5.0 (High) 25563361
acc2213 pp125FAK phosphorylation Tyr human Prostate Cancer PC3 Bombesin Associated 4.0 (Moderate) 9247295
acc2214 AKT phosphorylation Ser473 human Breast Cancer MDA-MB-468 Tamoxifen Associated 4.0 (Moderate) 29261144
acc2215 AKT phosphorylation Ser473 human Breast Cancer HCC-1937 Tamoxifen Associated 4.0 (Moderate) 29261144
acc2216 PRAS40 phosphorylation Thr246 human Prostate Cancer LNCaP AZD5363 Associated 4.0 (Moderate) 22294718
acc2217 PRAS40 phosphorylation Thr246 human Breast Cancer BT474c AZD5363 Associated 4.0 (Moderate) 22294718
acc2218 AKT phosphorylation Thr308 human Prostate Cancer LNCaP AZD5363 Associated 4.0 (Moderate) 22294718
acc2219 AKT phosphorylation Thr308 human Breast Cancer BT474c AZD5363 Associated 4.0 (Moderate) 22294718
acc2220 4EBP1 phosphorylation Ser65 human Prostate Cancer LNCaP AZD5363 Associated 4.0 (Moderate) 22294718
acc2221 4EBP1 phosphorylation Ser65 human Breast Cancer BT474c AZD5363 Associated 4.0 (Moderate) 22294718
acc2222 GSK3beta phosphorylation Ser9 human Prostate Cancer LNCaP AZD5363 Associated 4.0 (Moderate) 22294718
acc2223 GSK3beta phosphorylation Ser9 human Breast Cancer BT474c AZD5363 Associated 4.0 (Moderate) 22294718
acc2224 S6 phosphorylation Ser235 human Prostate Cancer LNCaP AZD5363 Associated 4.0 (Moderate) 22294718
acc2225 S6 phosphorylation Ser235 human Breast Cancer BT474c AZD5363 Associated 4.0 (Moderate) 22294718
acc2226 S6 phosphorylation Ser236 human Prostate Cancer LNCaP AZD5363 Associated 4.0 (Moderate) 22294718
acc2227 S6 phosphorylation Ser236 human Breast Cancer BT474c AZD5363 Associated 4.0 (Moderate) 22294718
acc2228 AKT phosphorylation Ser473 human Prostate Cancer LNCaP AZD5363 Associated 4.0 (Moderate) 22294718
acc2229 AKT phosphorylation Ser473 human Breast Cancer BT474c AZD5363 Associated 4.0 (Moderate) 22294718
acc2230 RB phosphorylation Ser807 human Esophageal Cancer OE19 5-FU Impairing 5.0 (High) 28734226
acc2231 RB phosphorylation Ser807 human Esophageal Cancer OE19 Cisplatin Enhancing 5.0 (High) 28734226
acc2232 RB phosphorylation Ser811 human Esophageal Cancer TE-13 5-FU Impairing 5.0 (High) 28734226
acc2233 RB phosphorylation Ser811 human Esophageal Cancer TE-13 Cisplatin Enhancing 5.0 (High) 28734226
acc2234 RB phosphorylation Ser807 human Esophageal Cancer OE21 5-FU Impairing 5.0 (High) 28734226
acc2235 RB phosphorylation Ser807 human Esophageal Cancer OE21 Cisplatin Enhancing 5.0 (High) 28734226
acc2236 RB phosphorylation Ser807 human Esophageal Cancer TE-13 5-FU Impairing 5.0 (High) 28734226
acc2237 RB phosphorylation Ser807 human Esophageal Cancer TE-13 Cisplatin Enhancing 5.0 (High) 28734226
acc2238 RB phosphorylation Ser811 human Esophageal Cancer OE19 5-FU Impairing 5.0 (High) 28734226
acc2239 RB phosphorylation Ser811 human Esophageal Cancer OE19 Cisplatin Enhancing 5.0 (High) 28734226
acc2240 RB phosphorylation Ser811 human Esophageal Cancer OE21 5-FU Impairing 5.0 (High) 28734226
acc2241 RB phosphorylation Ser811 human Esophageal Cancer OE21 Cisplatin Enhancing 5.0 (High) 28734226
acc2242 AXL phosphorylation Tyr702 human Glioblastoma Nivolumab Impairing 5.0 (High) 29531161
acc2243 eIF2alpha phosphorylation Ser51 human Hepatocellular Carcinoma HA22T apicidin Enhancing 5.0 (High) 31261976
acc2244 eIF2alpha phosphorylation Ser51 human Hepatocellular Carcinoma HA22T SAHA Impairing 5.0 (High) 31261976
acc2245 Chk1 phosphorylation Ser317 human Lung Cancer HTB182 Cisplatin Impairing 5.0 (High) 25937999
acc2246 Chk1 phosphorylation Ser345 human Lung Cancer HTB182 Cisplatin Impairing 5.0 (High) 25937999
acc2247 ATM phosphorylation Ser1981 human Lung Cancer HTB182 Cisplatin Enhancing 5.0 (High) 25937999
acc2248 Chk1 phosphorylation Ser317 human Lung Cancer CRL5985 Cisplatin Impairing 5.0 (High) 25937999
acc2249 Chk1 phosphorylation Ser345 human Lung Cancer CRL5985 Cisplatin Impairing 5.0 (High) 25937999
acc2250 ATM phosphorylation Ser1981 human Lung Cancer CRL5985 Cisplatin Enhancing 5.0 (High) 25937999